Rhumbline Advisers Nektar Therapeutics Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

A detailed history of Rhumbline Advisers transactions in Nektar Therapeutics stock. As of the latest transaction made, Rhumbline Advisers holds 185,116 shares of NKTR stock, worth $240,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,116
Previous 5,324 3377.01%
Holding current value
$240,650
Previous $4,000 5625.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
BUY
$0.9 - $1.83 $161,812 - $329,019
179,792 Added 3377.01%
185,116 $229,000
Q3 2023

Nov 09, 2023
SELL
$0.51 - $1.05 $4,446 - $9,154
-8,719 Reduced 62.09%
5,324 $3,000
Q2 2023

Aug 08, 2023
SELL
$0.53 - $1.03 $319,898 - $621,690
-603,583 Reduced 97.73%
14,043 $8,000
Q1 2023

May 11, 2023
BUY
$0.64 - $3.15 $26,072 - $128,324
40,738 Added 7.06%
617,626 $434,000
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $14,309 - $30,169
7,049 Added 1.24%
576,888 $1.3 Million
Q3 2022

Nov 10, 2022
BUY
$3.04 - $5.14 $50,433 - $85,272
16,590 Added 3.0%
569,839 $1.82 Million
Q2 2022

Aug 11, 2022
BUY
$3.17 - $6.17 $353,385 - $687,819
111,478 Added 25.23%
553,249 $2.1 Million
Q1 2022

May 12, 2022
BUY
$4.16 - $13.72 $37,814 - $124,714
9,090 Added 2.1%
441,771 $2.38 Million
Q4 2021

Feb 10, 2022
SELL
$10.83 - $18.41 $490,750 - $834,230
-45,314 Reduced 9.48%
432,681 $5.85 Million
Q3 2021

Nov 12, 2021
SELL
$13.07 - $18.84 $197,108 - $284,126
-15,081 Reduced 3.06%
477,995 $8.59 Million
Q2 2021

Aug 05, 2021
SELL
$16.52 - $20.4 $88,365 - $109,119
-5,349 Reduced 1.07%
493,076 $8.46 Million
Q1 2021

May 06, 2021
BUY
$16.56 - $25.46 $15,036 - $23,117
908 Added 0.18%
498,425 $9.97 Million
Q4 2020

Feb 10, 2021
BUY
$15.77 - $19.03 $303,288 - $365,984
19,232 Added 4.02%
497,517 $8.46 Million
Q3 2020

Nov 12, 2020
SELL
$16.59 - $24.79 $185,608 - $277,350
-11,188 Reduced 2.29%
478,285 $7.94 Million
Q2 2020

Aug 13, 2020
BUY
$16.86 - $23.44 $310,864 - $432,186
18,438 Added 3.91%
489,473 $11.3 Million
Q1 2020

May 06, 2020
BUY
$14.47 - $27.96 $476,439 - $920,610
32,926 Added 7.52%
471,035 $8.41 Million
Q4 2019

Feb 05, 2020
BUY
$15.87 - $23.12 $812,845 - $1.18 Million
51,219 Added 13.24%
438,109 $9.46 Million
Q3 2019

Oct 23, 2019
BUY
$16.91 - $36.27 $773,480 - $1.66 Million
45,741 Added 13.41%
386,890 $7.05 Million
Q2 2019

Aug 14, 2019
SELL
$31.0 - $36.3 $1.31 Million - $1.54 Million
-42,302 Reduced 11.03%
341,149 $12.1 Million
Q1 2019

May 01, 2019
SELL
$31.58 - $46.35 $454,688 - $667,347
-14,398 Reduced 3.62%
383,451 $12.9 Million
Q4 2018

Jan 31, 2019
BUY
$30.43 - $56.65 $941,260 - $1.75 Million
30,932 Added 8.43%
397,849 $13.1 Million
Q3 2018

Nov 07, 2018
BUY
$46.46 - $68.49 $20,581 - $30,341
443 Added 0.12%
366,917 $22.4 Million
Q2 2018

Aug 06, 2018
BUY
$46.25 - $104.45 $3.24 Million - $7.32 Million
70,094 Added 23.65%
366,474 $17.9 Million
Q1 2018

May 02, 2018
SELL
$57.4 - $108.44 $4.2 Million - $7.94 Million
-73,188 Reduced 19.8%
296,380 $31.5 Million
Q4 2017

Feb 09, 2018
BUY
$23.02 - $60.5 $1.2 Million - $3.16 Million
52,276 Added 16.48%
369,568 $22.1 Million
Q3 2017

Nov 06, 2017
BUY
$17.79 - $24.0 $5.64 Million - $7.62 Million
317,292
317,292 $7.62 Million

Others Institutions Holding NKTR

# of Institutions
140
Shares Held
135M
Call Options Held
32.8K
Put Options Held
55.5K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email